Tabor Asset Management LP Invests $338,000 in Bausch + Lomb Corporation (NYSE:BLCO)

Tabor Asset Management LP bought a new position in Bausch + Lomb Corporation (NYSE:BLCO - Free Report) in the first quarter, according to its most recent filing with the SEC. The firm bought 23,334 shares of the company's stock, valued at approximately $338,000.

Other institutional investors also recently bought and sold shares of the company. Allianz Asset Management GmbH acquired a new stake in Bausch + Lomb during the 1st quarter valued at approximately $4,712,000. Polar Asset Management Partners Inc. lifted its stake in Bausch + Lomb by 120.4% during the 4th quarter. Polar Asset Management Partners Inc. now owns 33,062 shares of the company's stock valued at $597,000 after acquiring an additional 18,062 shares during the period. Alpine Global Management LLC acquired a new stake in Bausch + Lomb during the 4th quarter valued at approximately $181,000. Tang Capital Management LLC lifted its stake in Bausch + Lomb by 28.6% during the 4th quarter. Tang Capital Management LLC now owns 450,000 shares of the company's stock valued at $8,127,000 after acquiring an additional 100,000 shares during the period. Finally, OCONNOR A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS LLC lifted its stake in Bausch + Lomb by 34.5% during the 4th quarter. OCONNOR A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 52,460 shares of the company's stock valued at $947,000 after acquiring an additional 13,460 shares during the period. 11.07% of the stock is currently owned by institutional investors and hedge funds.

Analyst Upgrades and Downgrades

Several analysts have commented on BLCO shares. Needham & Company LLC restated a "hold" rating on shares of Bausch + Lomb in a research note on Thursday, April 24th. HC Wainwright decreased their price objective on shares of Bausch + Lomb from $20.00 to $15.00 and set a "buy" rating for the company in a research note on Friday, May 2nd. Evercore ISI lifted their price objective on shares of Bausch + Lomb from $15.50 to $16.00 and gave the company an "outperform" rating in a research note on Tuesday, July 8th. Barclays cut their target price on shares of Bausch + Lomb from $19.00 to $16.00 and set an "equal weight" rating for the company in a report on Monday, June 9th. Finally, Wells Fargo & Company cut their target price on shares of Bausch + Lomb from $15.00 to $12.00 and set an "equal weight" rating for the company in a report on Thursday, May 1st. One equities research analyst has rated the stock with a sell rating, eight have issued a hold rating and three have given a buy rating to the company's stock. According to MarketBeat.com, Bausch + Lomb presently has a consensus rating of "Hold" and a consensus target price of $15.45.

Bausch + Lomb Price Performance

NYSE BLCO traded up $0.02 on Friday, hitting $13.99. The company had a trading volume of 93,092 shares, compared to its average volume of 758,220. The company has a market capitalization of $4.95 billion, a PE ratio of -13.55, a PEG ratio of 1.60 and a beta of 0.62. The company's fifty day moving average price is $12.59 and its 200-day moving average price is $14.07. The company has a debt-to-equity ratio of 0.74, a current ratio of 1.56 and a quick ratio of 0.96. Bausch + Lomb Corporation has a 12-month low of $10.45 and a 12-month high of $21.69.

Bausch + Lomb (NYSE:BLCO - Get Free Report) last issued its quarterly earnings results on Wednesday, April 30th. The company reported ($0.07) EPS for the quarter, missing the consensus estimate of $0.03 by ($0.10). The company had revenue of $1.15 billion during the quarter, compared to analysts' expectations of $1.15 billion. Bausch + Lomb had a positive return on equity of 2.62% and a negative net margin of 7.50%. Bausch + Lomb's revenue was up 3.5% compared to the same quarter last year. During the same period in the previous year, the firm posted $0.07 EPS. As a group, analysts predict that Bausch + Lomb Corporation will post 0.74 earnings per share for the current year.

Insider Buying and Selling

In related news, CEO Brent L. Saunders purchased 22,000 shares of the business's stock in a transaction that occurred on Thursday, May 22nd. The stock was bought at an average price of $11.28 per share, with a total value of $248,160.00. Following the acquisition, the chief executive officer owned 719,156 shares in the company, valued at $8,112,079.68. The trade was a 3.16% increase in their ownership of the stock. The purchase was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. Insiders own 0.76% of the company's stock.

Bausch + Lomb Profile

Bausch + Lomb Corporation operates as an eye health company in the United States, Puerto Rico, China, France, Japan, Germany, the United Kingdom, Canada, Russia, Spain, Italy, Mexico, Poland, South Korea, and internationally. It operates in three segments: Vision Care, Pharmaceuticals, and Surgical. The Vision Care segment provides contact lens that covers the spectrum of wearing modalities, including daily disposable and frequently replaced contact lenses; and contact lens care products comprising over-the-counter eye drops, eye vitamins, and mineral supplements that address various conditions, such as eye allergies, conjunctivitis, dry eye, and redness relief.